Skip to main content
BDX
NYSE Life Sciences

BD Guides FY Adjusted EPS to $13.10-$13.30

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$205.5
Mkt Cap
$56.981B
52W Low
$127.536
52W High
$209.835
52W Position info
61% above low
Off High info
2.1% below high
Rel. Volume info
2.6× avg
Market data snapshot near publication time

BDX sits 61% above its 52-week low of $127.536 on elevated volume (2.6× avg).

Summary

BD issued full-year adjusted EPS guidance of $13.10 to $13.30, and for fiscal 2027 it sees revenue up low-single digits. The stock is trading near its 52-week high, so the bar is already elevated. This follows the Q3 update in August, when adjusted EPS topped estimates and full-year guidance was raised, and comes after the October announcement of a $19 billion U.S. manufacturing expansion tied to tariff relief. In the fourth quarter BD reported revenue of $5.27B, net income of $696M, EPS of $2.54 and adjusted EPS of $4.15, which beat the IBES estimate. The guidance range is the key number to square against consensus; the added revenue outlook gives it more to work with than the EPS range alone.

At the time of this announcement, BDX was trading at $205.50 on NYSE in the Life Sciences sector, with a market capitalization of approximately $57B. The 52-week trading range was $127.54 to $209.84. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

BDX - Latest Insights

BDX
Nov 05, 2026, 6:54 AM EST
Source: dpa-AFX
Importance Score:
7
Price at Filing: $206.00
Real-time Price: $212.96 info
Change: +$6.96 (+3%) info
Market Cap: $57.968B info
BDX
Nov 05, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $204.07
Real-time Price: $212.96 info
Change: +$8.89 (+4%) info
Market Cap: $57.968B info
BDX
Oct 07, 2026, 1:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $181.41
Real-time Price: $212.96 info
Change: +$31.56 (+17%) info
Market Cap: $57.968B info
BDX
Oct 07, 2026, 8:20 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $177.43
Real-time Price: $212.96 info
Change: +$35.53 (+20%) info
Market Cap: $57.968B info
BDX
Oct 06, 2026, 7:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $182.00
Real-time Price: $212.96 info
Change: +$30.96 (+17%) info
Market Cap: $57.968B info